We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CTI Announces Results from Sub-Set Analyses of Data from Phase 3 EXTEND Clinical Trial

News   Jul 15, 2013

 
CTI Announces Results from Sub-Set Analyses of Data from Phase 3 EXTEND Clinical Trial
 
 
 

RELATED ARTICLES

Shortage of Gene Silencing Molecules Linked to Pediatric Brain Tumor Development

News

Researchers have added to evidence that a shortage of specific tiny molecules that silence certain genes is linked to the development and growth of pediatric brain tumors known as low-grade gliomas.

READ MORE

Immune Cells Double-check to Determine if Cells are Cancerous

News

Gamma Delta T cells possess a unique two-pronged device, allowing them to double-check whether the body's cells are healthy or dangerous before deciding whether to kill them.

READ MORE

Obesity and Cancer: ‘Fat-clogged’ Immune Cells Fail to Fight Tumors

News

Researchers have gained a new understanding of the link between obesity and cancer. In the presence of excess fat, the immune surveillance system fails due to an obesity-fueled lipid accumulation in natural killer (NK) cells, preventing their cellular metabolism and trafficking.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE